التفاصيل البيبلوغرافية
| العنوان: |
Childhood Asthma and Covid 19. |
| المؤلفون: |
UYSAL SOYER, Özge1 ozgeusoyer@gmail.com |
| المصدر: |
Asthma Allergy Immunology / Astim Allerji Immunoloji. 2020 Supplement, Vol. 18, p11-14. 4p. |
| مصطلحات موضوعية: |
*PREVENTIVE medicine, *ASTHMA in children, *B cells, *CHRONIC diseases, *DEATH, *IMMUNOSUPPRESSION, *INFLAMMATION, *LUNG diseases, *RESPIRATORY organ sounds, *RISK assessment, *T cells, *COMORBIDITY, *DISEASE relapse, *DISEASE exacerbation, *LYMPHOPENIA, *COVID-19, *CYTOKINE release syndrome, *CHILDREN |
| مستخلص: |
Coronavirus disease 2019 (Covid 19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV 2) and causes lymphopenia, immunosuppression, inefficient T and B cell immunity, cytokine storm, and destructive tissue inflammation. Since COVID 19 is a multi-system disease predominantly affecting the lungs, there is doubt on whether chronic lung diseases place patients at higher risk and SARS CoV2 leads to asthma exacerbation. None of the studies have reported asthma or recurrent wheezing as a comorbidity or risk factor for Covid 19 in children up to now. Notably, further studies are needed to explore the relationship between Covid 19 and asthma to improve clinical practice and decrease morbidity and mortality. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
